BC
WHWK

Bartlett & Co’s Whitehawk Therapeutics WHWK Stock Holding History

Bartlett & Co’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$3K Hold
1,333
– – ﹤0.01% 1134
2023
Q3 		$6K Hold
1,333
– – ﹤0.01% 980
2023
Q2 		$9K Hold
1,333
– – ﹤0.01% 941
2023
Q1 		$10K Hold
1,333
– – ﹤0.01% 829
2022
Q4 		$17K Hold
1,333
– – ﹤0.01% 753
2022
Q3 		$19K Buy
+1,333
New +$17.5K ﹤0.01% 719

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bartlett & Co's WHWK Position: Q4 2023 in Review

Bartlett & Co held its Whitehawk Therapeutics (WHWK) position steady in Q4 2023 at 1,333 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Bartlett & Co first reported a position in WHWK in Q3 2022 and has held it in 6 quarters since. The position peaked at $19K in Q3 2022. 65 funds tracked by Wall St. Rank hold WHWK as of Q4 2023.

  • Bartlett & Co held 1,333 shares of Whitehawk Therapeutics worth $3K as of Q4 2023.
  • Bartlett & Co left its Whitehawk Therapeutics share count unchanged in Q4 2023.
  • Whitehawk Therapeutics made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1134 holding.
  • Bartlett & Co first reported a position in Whitehawk Therapeutics in Q3 2022 and has held it in 6 quarters since.
  • Bartlett & Co's Whitehawk Therapeutics position peaked at $19K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.